CureLab Oncology, Inc.
About CureLab Oncology, Inc.CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.
Please click here for Curelab Oncology job opportunities.
5 articles with CureLab Oncology, Inc.
CureLab Oncology Granted US Patent for Therapeutic Use of its Lead Product in ALS, Alzheimer's, Huntington's, and Parkinson's Diseases
CureLab Oncology, a clinical-stage biotech company, has been granted a US patent for the application of its lead product for the treatment of ALS, Alzheimer's, Huntington's, and Parkinson's disease.
Based on a scientifically solid proof of concept in dogs and cats, an international IP portfolio, and a comprehensive scientific advisory board that includes key opinion leaders and experienced management, CureLab Veterinary intends to raise initial financing through a crowdfunding campaign set to launch within a month, and to become profitable within 36 months of raising funds.
CureLab Oncology, a clinical-stage pre-IPO biotech company, has commenced operations in the GCC region.
Former US Secretary of Veterans Affairs and internationally known healthcare industry leader to advise on partnerships for upcoming clinical trials and market entry strategy for CureLab's Elenagen cancer therapy
CureLab Oncology Publishes Proof Of Concept Demonstrating That Its Product Can Reduce Metabolic Disorders Induced By Excessive Food Consumption